Universe Pharmaceuticals Inc (UPC): R&D Expense
Figures out of scale. In this company's filings, reported revenue for the year ended 2023-09-30 is more than 100 times total assets. That usually means a value was tagged in the wrong unit. Figures are shown as filed; growth rates are not computed, and the company is left out of screens and comparisons.
$671.76M
Year ended 2025-09-30. As filed; likely tagged in the wrong unit
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-09-30 | $671.76M | n/a | 2026-01-29, From 2024-10-01 |
| 2024-09-30 | $3.03B | n/a | 2026-01-29, From 2023-10-01 |
| 2023-09-30 | $4.86B | n/a | 2026-01-29, From 2022-10-01 |
| 2022-09-30 | $7.64M | n/a | 2025-04-29, From 2021-10-01 |
| 2021-09-30 | $5.47M | n/a | 2024-01-30, From 2020-10-01 |
| 2020-09-30 | $583.1K | n/a | 2023-02-10, From 2019-10-01 |
| 2019-09-30 | $618.4K | n/a | 2022-01-31, From 2018-10-01 |